ReWalk(US:LFWD)2019-02-08 15:43Financial Data and Key Metrics Changes - In Q4 2018, the company reported revenue of $1.6 million, with a total revenue of $6.5 million for the full year [7][15] - The net loss for Q4 2018 was $5 million, an improvement from a net loss of $6.2 million in Q4 2017. The full year net loss was $21.7 million compared to $24.7 million in 2017 [19] - Gross margin for Q4 2018 was 39%, with an adjusted margin over 50% excluding a one-time expense [17] Business Line Data and Key Metrics Changes - The company placed 19 units in Q4 2018, with 15 units in Europe and 4 in the U.S. For the full year, 85 units were placed, with 42 in the U.S. and 40 in Europe [15] - The ReStore system for stroke patients is set to launch, with a 510(k) submission to the FDA imminent and a potential launch in late Q2 or Q3 2019 [11][12] Market Data and Key Metrics Changes - In Germany, the company achieved a reimbursement model, resulting in $1.24 million in revenue and 15 placed devices in Q4 2018 [7][8] - The U.S. market remains challenging due to reimbursement issues, but there is a strong backlog of demand for ReWalk devices [9][10] Company Strategy and Development Direction - The company aims to complete the submission for FDA clearance of the ReStore soft exo-suit and prepare for its launch in both the U.S. and Europe [21] - The strategy includes engaging with U.S. insurers for broader reimbursement coverage and initiating commercial preparations in China [21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the momentum in Europe for SCI devices and the upcoming launch of the ReStore for stroke patients [21] - The company remains focused on reducing operating expenses and improving margins to establish a pathway to breakeven [21] Other Important Information - The company raised approximately $13.1 million in gross proceeds in November 2018, with part used to repay debt [19] - The company ended 2018 with $9.5 million in cash and reduced its cash burn to $14.8 million from $22.5 million in 2017 [19] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.